1. 1. Hashemzadeh S, Aligholipour Maleki R, Golzari SE. The incidence of breast cancer in northwest iran (2003 -2008). J Cardiovasc Thorac Res 2012;4(1):5–9.
2. 2. Duffy M. CA 15-3 and related mucins as circulating markers in breast cancer. Ann Clin Biochem 1999; 5: 579-86.
3. 3. Man Y, Stojadinovic A, Mason J. Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories. J Cancer 2013; 4(1): 84–95.
4. 4. Kahlenborn C, Modugno F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc 2006; 81(10): 1290-302.
5. 5. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012; 156(9): 635-48.
6. 6. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992; 23(3): 211-8.
7. 7. Townsend CM, Jr. Treatment of breast cancer. Clin Symp 1997; 49(1):1-32.
8. 8. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136–46.
9. 9. Stockler M, Wilcken NR, Ghersi D, Simes RJ. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 2000;26(3):151-68.
10. 10. Sieval A, Thanou M, Kotze A.F, Verhoef C.J, Brussee J, Junginger H.E. Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohydrt Polym 1998; 36, 157–65.
11. 11. Grinberg O, Gedanken A, Patra CR, Patra S, Mukherjee P, Mukhopadhyay D. Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics. Acta Biomater 2009;5(8):3031–7.
12. 12. Tan ML, Choong PF, Dass CR. Review: doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol 2009; 61(2): 131-42.
13. 13. Saremi Sh, Atyabi F, Parinaz Akhlaghi S, Nasser Ostad S, Dinarvand R. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Int J Nanomedicine 2011; 6: 119–28.
14. 14. Soleimani N, Mobarez A, Jafari Olia M, Atyabi F. Synthesis, Characterization and Effect of the Antibacterial Activity of Chitosan Nanoparticles on Vancomycin- Resistant Enterococcus and Other Gram Negative or Gram Positive Bacteria. Int J Pure Appl Sci Tech 2015: 26(1): 14-23.
15. 15. Hosseinzadeh H, Atyabi F, Dinarvand R, Naser Ostad S. Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine 2012; 7: 1851–63.
16. 16. Soleimani N, Mohabati-Mobarez A, Atyabi F, Hasan-Saraf Z, Haghighi M. Preparation of chitosan nanoparticles carrying recombinant helicobacter pylori neutrophil-activating protein. J Mazandaran Univ Med Sci 2014; 23 (2) 23 (2):134-44.
17. 17. Daneshmandi S, Hajimoradi M, Soleimani N, Sattari M. Modulatory effect of Acetobacter xylinum cellulose on peritoneal macrophages. Immunopharmacol Immunotoxicol2011: 33 (1), 164-8.
18. 18. Yousofi A, Daneshmandi S, Soleimani N, Bagheri K, Karimi MH. Immunomodulatory effect of Parsley (Petroselinum crispum) essential oil on immune cells: mitogen-activated splenocytes and peritoneal macrophages. Immunopharmacol Immunotoxicol 2012: 34 (2), 303-8.
19. 19. Vila A and et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 2004; 57: 123-31.
20. 20. Zhang H, Wu S, Tao Y, Zang L, Su Z. Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system. J Nanomaterials 2010;5:1–5.
21. 21. Potdar PD, Shetti AU. Evaluation of antimetastatic effect of chitosan nanoparticles on esophageal cancer associated fibroblasts. J Cancer Metasta Treat 2016;2:259-67.
22. 22. Solomon W, Leung Wenjuan G, Tae Hwan James C.K. Lai Effect of Chitosan and Nanoparticles on Cancer Cells Treated with Therapeutic Drugs: Comparison of Cell Survival, advance in nano biomechanics robot and energy research, the world congress, 2013.
23. 23. Wimardhani YS, Suniarti DF, Freisleben HJ, Wanandi SI, Siregar NC, Ikeda M-A. Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells. J Oral Sci 2014;56(2):119–26.
24. 24. Rauw F, Gardin Y, Palya V, Anbari S, Gonze M, Lemaire S, et al. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol 2010;134(3–4):249–58.
25. 25. Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine 2006;1(2):117-28.
26. Gregory AE, Titball R, Williamson D. Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 2013;3:13.